ArticleNPJ breast cancer2020

The Prosigna 50-gene profile and responsiveness to adjuvant anthracycline-based chemotherapy in high-risk breast cancer patients.

Maj-Britt Jensen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.